Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 1/20 | 0.49 |
| ▸ | IMPDH2 | P12268 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.44 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.44 |
| ▸ | PIM1 | P11309 | 6/20 | 0.44 |
| ▸ | PIM3 | Q86V86 | 6/20 | 0.44 |
| ▸ | PIM2 | Q9P1W9 | 4/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | TDO2 | P48775 | 7/20 | 0.43 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18552020 | 0.84 | NR4A2 (0.49) | NR4A2IMPDH2MAPK1HSD17B10PDGFRB | |
| SCHEMBL18552202 | 0.84 | TDO2 (0.51) | NR4A2IMPDH2MAPK1HSD17B10PDGFRB | |
| SCHEMBL24022684 | 0.83 | IMPDH2 (0.61) | NR4A2IMPDH2MAPK1HSD17B10PIM1 | |
| SCHEMBL18552198 | 0.83 | IMPDH2 (0.61) | NR4A2IMPDH2MAPK1HSD17B10PIM1 | |
| SCHEMBL18552149 | 0.83 | IMPDH2 (0.61) | NR4A2IMPDH2MAPK1HSD17B10PIM1 | |
| SCHEMBL24022670 | 0.82 | PIM1 (0.50) | NR4A2IMPDH2MAPK1HSD17B10PDGFRB | |
| SCHEMBL24174562 | 0.75 | ALDH1A1 (0.59) | MAPK1HSD17B10ALOX5 | |
| Biphenyl SCHEMBL4006358 | 0.75 | ALDH1A1 (0.59) | MAPK1HSD17B10ALOX5 | |
| SCHEMBL28416622 | 0.75 | NR4A2 (0.78) | NR4A2IMPDH2MAPK1HSD17B10PDGFRB | |
| SCHEMBL29476053 | 0.74 | AHR (0.46) | MAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11177443-B2 | Compound and light emitting diode including same | LMS CO., LTD (KR) | 2021-11-16 | — | — | US | disclosed |
| WO-2017030424-A1 | NOVEL COMPOUND AND LIGHT EMITTING DIODE INCLUDING SAME | 주식회사 엘엠에스 | 2017-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11177443-B2 | Compound and light emitting diode including same | ARL1, ALDH1A2, DRD1 | NR4A2 646/4885IMPDH2 2711/4885MAPK1 390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.